Lantheus Holdings, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Lantheus Holdings, Inc. payments for repurchase of common stock for the quarter ending 2025-12-31 was $100.02M, a 0.02% increase year-over-year.
- Lantheus Holdings, Inc. payments for repurchase of common stock for the quarter ending 2025-09-30 was $100.00M.
- Lantheus Holdings, Inc. payments for repurchase of common stock for the quarter ending 2024-12-31 was $100.00M.
- Lantheus Holdings, Inc. payments for repurchase of common stock for the quarter ending 2024-09-30 was $0.00.
- Lantheus Holdings, Inc. payments for repurchase of common stock for fiscal 2025 was $300.02M, a 200.02% increase from fiscal 2024.
- Lantheus Holdings, Inc. payments for repurchase of common stock for fiscal 2024 was $100.00M.
- Lantheus Holdings, Inc. payments for repurchase of common stock for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Lantheus Holdings, Inc. payments for repurchase of common stock for fiscal 2022 was $75.00M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-12-31 | $100.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $300.02M 10-K · filed 2026-02-26 |
| 2025-09-30 | $100.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2024-12-31 | $100.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $100.00M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 | |
| 2022-12-31 | $75.00M 10-K · filed 2025-02-26 | |
| 2021-12-31 | $0.00 10-K · filed 2024-02-22 | |
| 2020-12-31 | $0.00 10-K · filed 2023-02-23 | |
| 2013-12-31 | $106.00K 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |